Anavex Life Sciences
AVXL
AVXL
58 hedge funds and large institutions have $28.4M invested in Anavex Life Sciences in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $32.6M → $28.4M (-$4.27M)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
68% less call options, than puts
Call options by funds: $264K | Put options by funds: $818K
Holders
58
Holding in Top 10
1
Calls
$264K
Puts
$818K
Top Buyers
| 1 | +$832K | |
| 2 | +$138K | |
| 3 | +$114K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$107K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$97.6K |
Top Sellers
| 1 | -$525K | |
| 2 | -$156K | |
| 3 | -$145K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$84.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$83.3K |